von Tobias Borgers | Feb 27, 2021 | Frewitt
Gilead Sciences has completed the previously announced acquisition of cancer therapies developer Immunomedics for approximately $21bn. In September, Gilead signed a definitive merger agreement to acquire all the outstanding shares of Immunomedics at a price of $88 per...
von Tobias Borgers | Feb 27, 2021 | Bosch
The market research report is the new statistical data source added by Contrive Datum Insights. It uses several approaches for analyzing the data of the target market such as primary and secondary research methodologies. It includes investigations based on historical...
von Tobias Borgers | Feb 25, 2021 | Tablet Coating
Editor’s note: The N.C. Biotech Center and WRAL TechWire announced recently the launch of the Bio Jobs Hub, a project designed to match workers and employers in the growing NC life science community. Each Wednesday TechWire plans to feature a story about what’s...
von Tobias Borgers | Feb 18, 2021 | Continuous Manufacturing
Global Continuous Manufacturing Market: Snapshot The global continuous manufacturing market is anticipated to gain impetus due to the development of the pharmaceutical industry. Other important factors that could enhance the growth of the market could be quicker...
von Tobias Borgers | Jan 29, 2021 | Fette
The pharmaceutical continuous manufacturing market is expected to reach US$ 3,064.38 million by 2027 from US$ 1,459.53 million in 2019. The market is estimated to grow at a CAGR of 9.8% from 2020 to 2027. Continuous manufacturing in the pharmaceuticals industry is a...
